Intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trial
Nicholas A. Vitanza(Seattle Children's Hospital), Michael C. Jensen(Seattle Children's Hospital), Juliane Gust(University of Washington), Catherine Lindgren(Unknown), Sowmya Pattabhi, Jason S. Hauptman(Seattle Children's Hospital), Susan Holtzclaw(Seattle Children's Hospital), Julie R. Park(Seattle Children's Hospital), Rimas J. Orentas(Capital Caring), Matthew D. Dun(Hunter Medical Research Institute), Hannah E. Goldstein(Seattle Children's Hospital), Joshua A. Gustafson(Seattle Children's Hospital), Michelle Choe(Baylor College of Medicine), Ashley Wilson(Center for Infectious Disease Research), Jessica Foster(Children's Hospital of Philadelphia), Erin Crotty(Seattle Children's Hospital), Catherine M. Albert(Seattle Children's Hospital), Rebecca Ronsley(Seattle Children's Hospital), Francisco A. Perez(Seattle Children's Hospital), Sarah Leary(Seattle Children's Hospital), Stephanie Rawlings-Rhea(Seattle Children's Hospital), Wenjun Huang(Lishui Central Hospital), Jason N. Wright(Seattle Children's Hospital), Jeffrey G. Ojemann(Seattle Children's Hospital), Jason Wendler(Pacific Northwest National Laboratory), Ada Kong(Seattle Children's Hospital), Amy Lee(Seattle Children's Hospital), Rebecca Gardner(Seattle Children's Hospital), Navin Pinto(Seattle Children's Hospital), Kristy Seidel(Fred Hutch Cancer Center), Amy Wein(Seattle Children's Hospital), Samuel R. Browd(Seattle Children's Hospital), Adam Beebe, Colleen Annesley(Unknown), Christopher Brown, On Ho, Alison Thomsen(Seattle Children's Hospital), Madison Beam, Marta M. Alonso(BioCruces Health research Institute), Leonel Steinmetzer, Corrine Hoeppner(Seattle Children's Hospital)
Cited by 154
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
|New England Journal of Medicine|2016|1.8k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k